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ABSTRACT
Endometriosis is a very common benign condition affecting fertility and quality of life. Different methods, either definitive or fertility 
sparing are used for its management by using open, laparoscopic, and robotic techniques. This is a literature review presenting the role 
and the advantages of robotic surgery in endometriosis. Such a management is effective, safe, and feasible in hands of well-trained 
multidisciplinary teams even for severe cases of endometriosis.
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INTRODUCTION
Endometriosis occurs in 5–15% of the general population 
and although a benign condition, sometimes it might re-
quire difficult surgical dissections as it could be locally in-
filtrative, invasive, and widely disseminated. The typical 
patient is nulliparous, infertile, and around 30-years-old. 
The most common sites of endometriosis intra-abdomi-
nally include adnexae (two out of three cases), pouch of 
Douglas, uterosacral and broad ligaments, uterovesical 
fold, ureters, bladder, appendix, rectosigmoid colon or 
caecum, and small bowel loops (1, 2).
The treatment options of endometriosis include med-
ical (e.g. progestins, danazol, GnRH- analogues) or sur-
gical options which could be classified as most definitive 
(including hysterectomy and bilateral salpingo-oophorec-
tomy) or fertility-sparing with the aim to excise all perito-
neal endometriotic implants and adhesions but preserve 
fertility (3–6). Laparoscopic or open techniques, depend-
ing on each surgeon’s preference and experience, are of-
fered as treatment options, while recently robotic proce-
dures are also suggested.
The da Vinci© surgical system received FDA approval 
in 2005. Robotic procedures have been introduced in or-
der to improve surgical performance. Increased dexterity, 
greater range of motion, and better depth perception are 
the main advantages of robotic-assisted techniques (7). Its 
limitations include lack of tactile feedback and increased 
cost (8). Robotic procedures combine the advantages of 
open and laparoscopic procedures and are another alter-
native in the management of endometriosis.
The aim of this narrative review is to present the use, 
the criteria, and the advantages of robotic surgery in the 
treatment of endometriosis.
DISCUSSION
Different techniques including open, laparoscopic or ro-
botic procedures can equally be used in the management 
of endometriosis (9–11). The patient is preoperatively as-
sessed with imaging scans including ultrasound and MRI 
and she signs the informed consent when she is informed 
about the type of planned procedure and possible risks 
of it including infection, bleeding, and injury of adjacent 
organs. Multidisciplinary experts, including gynaecolo-
gists, urologists, and general surgeons, should cooperate 
in order to achieve the optimal outcome in the most severe 
cases.
Fertility-sparing techniques are used in order to de-
stroy all endometriotic implants and remove all the possi-
ble adhesions. Removal and not lysis of them is preferred. 
Endometriomas larger than 3 cm are also excised either 
with cystectomy, or if  that is not technically possible, 
with oophorectomy. If tubes are affected, salpingectomy 
is performed and IVF procedures are used for pregnancy 
achievement. If both adnexae are affected and bilateral 
salpingo-oophorectomy is essential, the uterus is pre-
served and donor eggs could be used for pregnancy. In ro-
botic cases, all endometriotic implants are either excised 
or destroyed with scissors or diathermy. Segmental bowel 
resections, rectal shaving, and partial bladder resection 
are described in the literature (12). Ureteral endometriosis 
could be treated with partial ureterectomy and ureterone-
ocystostomy (13). Special care should be taken during the 
excision from small or large bowel and/or urinary tract to 
avoid any injuries. However, deep infiltrative endometri-
osis of the rectovaginal septum is one of the most severe 
types of endometriosis (14). For this reason, any hidden 
endometriosis should be completely excised to avoid de-
veloping deeper nodular lesions in the future (14). It was 
recently shown that infiltrating colorectal endometriosis 
could be safely and effectively treated robotically even by 
performing a rectosigmoidectomy if that is essential (1). In 
case of most definitive techniques, total or even modified 
radical hysterectomies plus bilateral salpingooophorecto-
mies might be essential to treat the disease. Of course, as 
in open and laparoscopic techniques, preoperative use of 
GnRH analogues for three to six months can improve sur-
gical success.
Robotic system preserves the advantages of conven-
tional laparoscopy while it offers the possibility to the 
gynaecologist to dissect down and into the narrow pel-
vic floor. It is suggested that a  diagnostic laparoscopy 
should be used in order to clarify the range of the disease 
in the upper abdomen before docking the robot in order 
to know exactly where the disease is. In robotic systems, 
the CO2 pressure required for exposure is often lower in 
correlation with traditional laparoscopy as result of the 
mechanical lift of the robot (15). Robotic procedures can 
be safely performed after taking into account the physi-
ological changes of pneumoperitoneum and steep Tren-
delenburg position during a  preoperative anaesthetic 
review (16). Robotics, also shares similar benefits of lapa-
roscopy including smaller incisions (at most 10 to 12 mm) 
(15). The three-dimensional stereoscopic vision by the use 
of binocular optics, the filtration of the tremor, and the 
less operator fatigue are some of the obvious advantages 
of such operations. The articulated instruments permit 
a wide range of motions while they increase the ability of 
the surgeon to work efficiently. All the above mentioned 
advantages can lead to more anatomical procedures. In 
addition, the 360° motion of the robotic wrist permits the 
fine adhesiolysis and removal of any suspicious nodule, 
even if it is quite deep. More specifically, Patzkowsky et 
al., comparing robotic to laparoscopic treatment in over 
500 patients, showed that age, body mass index, opera-
tive time, and estimated blood loss were not statistical-
ly different between the two procedures. Furthermore, 
robotic techniques could be easier used in larger uterus, 
cases with more severe adhesions, and stage III-IV endo-
metriosis (17). However, the rates of urinary tract infec-
tions were higher in the robotic group (17). According to 
another study, including women treated with robotic-as-
sisted laparoscopy for stage III and IV endometriosis, the 
median actual surgical time was 145 minutes (ranging 
from 67 to 325 minutes), while the median blood loss was 
100 ml (ranging from 20 to 400 ml) depending on the se-
verity of the case and the experience of the surgeon (18). 
Another study group, showed that uterine weight higher 
than 250 grams and older age predispose to longer surgi-
cal time (19). In all those studies, the rates of conversion 
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to open surgery and blood transfusion are minimal. So, 
the robotic assisted surgery also permits the realization 
of a key hole operation which can be interpreted into sig-
nificantly less blood loss, less pain, shorter recovery time, 
as well as shorter hospital stay and better aesthetic result. 
Additionally, a shorter hospital stay and a quicker return 
to normal activity may mean less postoperative problems 
such as infection or pulmonary embolism. Last but not 
least, the use of robotic systems gives the opportunity of 
rapid acquisition of surgical skills required in order to 
perform laparoscopic surgery, while at the same time en-
able gynaecologists to reach at least as good clinical out-
comes as conventional laparoscopy and within shorter 
operating times once they exceed the initial stage of the 
learning curve.
On the other hand, the high costs of use, the bulky 
machinery, and the need for staff training are the most 
important drawbacks in the utilization of robot in such 
operations. Of course, entry of new robotic systems in the 
market, as well as the use of the robot by different surgi-
cal teams, and in a high volume of patients could decrease 
the cost disadvantage. Short term complications include 
vaginal cuff abscess (18), ureterovaginal fistulas (20), and 
higher rates of urinary tract infection caused by extend-
ed use of Folley catheter for urinary retention (21). A rare 
case of rhabdomyolysis and compartment syndrome, after 
a 12-hour duration robotic operation, is also presented in 
the literature (22), showing the need for training and time 
managing of such operations. Although larger prospective 
studies as well as longer follow-up periods are necessary to 
clarify the long term outcomes including fertility results, 
pain, and quality of life, it seems that robotic management 
of even severe cases of endometriosis is an effective, fea-
sible, and safe alternative in well-trained hands as it was 
also shown in a recent systematic review (23) and can be 
used without compromising the principles of open or lap-
aroscopic operations.
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